1380 related articles for article (PubMed ID: 28799247)
1. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
3. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
4. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
6. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
[TBL] [Abstract][Full Text] [Related]
8. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
[TBL] [Abstract][Full Text] [Related]
9. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
11. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibition reverses impaired Ca
Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
[TBL] [Abstract][Full Text] [Related]
13. Moderate Exercise in Spontaneously Hypertensive Rats Is Unable to Activate the Expression of Genes Linked to Mitochondrial Dynamics and Biogenesis in Cardiomyocytes.
Quiroga C; Mancilla G; Oyarzun I; Tapia A; Caballero M; Gabrielli LA; Valladares-Ide D; Del Campo A; Castro PF; Verdejo HE
Front Endocrinol (Lausanne); 2020; 11():546. PubMed ID: 32973679
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
15. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
[TBL] [Abstract][Full Text] [Related]
16. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
18. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.
Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M
Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852
[TBL] [Abstract][Full Text] [Related]
19. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
[TBL] [Abstract][Full Text] [Related]
20. Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failure.
Zhou N; Chen X; Xi J; Ma B; Leimena C; Stoll S; Qin G; Wang C; Qiu H
Redox Biol; 2020 Sep; 36():101662. PubMed ID: 32795937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
